Financial Gravity Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-39
Closed -$632 1838
2023
Q2
$632 Buy
+39
New +$1.38K ﹤0.01% 948
2023
Q1
Sell
-21
Closed -$177 1755
2022
Q4
$177 Buy
+21
New +$448 ﹤0.01% 1003

Financial Gravity Asset Management's ISEE Position: Q3 2023 in Review

Financial Gravity Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 39 shares — an estimated $632 sold.

Financial Gravity Asset Management first reported a position in ISEE in Q4 2022 and held it in 2 quarters. The position peaked at $632 in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Financial Gravity Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Financial Gravity Asset Management sold 39 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $632.
  • Financial Gravity Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Financial Gravity Asset Management's IVERIC bio, Inc. Common Stock position peaked at $632 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Financial Gravity Asset Management's 13F filing for Q3 2023, filed 16 Nov 2023.